Bilaketaren emaitzak - Vladimir Tolmachev

Findu emaitzak
  1. 1
    Affibody Molecules as Targeting Vectors for PET Imaging

    Affibody Molecules as Targeting Vectors for PET Imaging nork Vladimir Tolmachev, Anna Orlova

    Argitaratua 2020
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Methods for Radiolabelling of Monoclonal Antibodies

    Methods for Radiolabelling of Monoclonal Antibodies nork Vladimir Tolmachev, Anna Orlova, Karl Andersson

    Argitaratua 2013
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors: Direct Comparison of a <sup>124</sup>I-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model

    On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors: Direct Comparison of a <sup>124</sup>I-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model nork Anna Orlova, Helena Wållberg, Sharon Stone‐Elander, Vladimir Tolmachev

    Argitaratua 2009
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond

    Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond nork Javad Garousi, Anna Orlova, Fredrik Y. Frejd, Vladimir Tolmachev

    Argitaratua 2020
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications

    Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications nork John Löfblom, Joachim Feldwisch, Vladimir Tolmachev, J. Carlsson, S. Ståhl, Fredrik Y. Frejd

    Argitaratua 2010
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Tumor Targeting Using Affibody Molecules: Interplay of Affinity, Target Expression Level, and Binding Site Composition

    Tumor Targeting Using Affibody Molecules: Interplay of Affinity, Target Expression Level, and Binding Site Composition nork Vladimir Tolmachev, Thuy Tran, Daniel Rosik, Anna Sjöberg, Lars Abrahmsén, Anna Orlova

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain

    Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain nork Jan Terje Andersen, Rikard Pehrson, Vladimir Tolmachev, Muluneh Bekele Daba, Lars Abrahmsén, Caroline Ekblad

    Argitaratua 2010
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Affibody-mediated PET imaging of HER3 expression in malignant tumours

    Affibody-mediated PET imaging of HER3 expression in malignant tumours nork Maria� Rosestedt, Karl Andersson, Bogdan Mitran, Vladimir Tolmachev, John Löfblom, Anna Orlova, Stefan Ståhl

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Selection and characterization of HER2/neu-binding affibody ligands

    Selection and characterization of HER2/neu-binding affibody ligands nork Maria Wikman, A.-C. Steffen, Elin Gunneriusson, Vladimir Tolmachev, Gregory P. Adams, J. Carlsson, S. Ståhl

    Argitaratua 2004
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Feasibility of Affibody Molecule-Based PNA-Mediated Radionuclide Pretargeting of Malignant Tumors

    Feasibility of Affibody Molecule-Based PNA-Mediated Radionuclide Pretargeting of Malignant Tumors nork Hadis Honarvar, Kristina Westerlund, Mohamed Altai, Mattias Sandström, Anna Orlova, Vladimir Tolmachev, Amelie Eriksson Karlström

    Argitaratua 2015
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Influence of Nuclides and Chelators on Imaging Using Affibody Molecules: Comparative Evaluation of Recombinant Affibody Molecules Site-Specifically Labeled with <sup>68</sup>Ga and <sup>111</sup>In via Maleimido Derivatives of DOTA and NODAGA

    Influence of Nuclides and Chelators on Imaging Using Affibody Molecules: Comparative Evaluation of Recombinant Affibody Molecules Site-Specifically Labeled with <sup>68</sup>Ga and... nork Mohamed Altai, Joanna Strand, Daniel Rosik, Ram Kumar Selvaraju, Amelie Eriksson Karlström, Anna Orlova, Vladimir Tolmachev

    Argitaratua 2013
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Influence of Macrocyclic Chelators on the Targeting Properties of 68Ga-Labeled Synthetic Affibody Molecules: Comparison with 111In-Labeled Counterparts

    Influence of Macrocyclic Chelators on the Targeting Properties of 68Ga-Labeled Synthetic Affibody Molecules: Comparison with 111In-Labeled Counterparts nork Joanna Strand, Hadis Honarvar, Anna Perols, Anna Orlova, Ram Kumar Selvaraju, Amelie Eriksson Karlström, Vladimir Tolmachev

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Molecular Design and Optimization of <sup>99m</sup>Tc-Labeled Recombinant Affibody Molecules Improves Their Biodistribution and Imaging Properties

    Molecular Design and Optimization of <sup>99m</sup>Tc-Labeled Recombinant Affibody Molecules Improves Their Biodistribution and Imaging Properties nork Helena Wållberg, Anna Orlova, Mohammed Altai, Seyed Jalal Hosseinimehr, Charles Widström, Jennie Malmberg, Stefan Ståhl, Vladimir Tolmachev

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Molecular Imaging of <i>HER2</i>-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic <sup>111</sup>In- or <sup>68</sup>Ga-Labeled Affibody Molecules

    Molecular Imaging of <i>HER2</i>-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic <sup>111</sup>In- or <sup>68</sup>Ga-Labeled Affibody Molecules nork Richard P. Baum, Vikas Prasad, Dirk Müller, Christiane Schuchardt, Anna Orlova, Anders Wennborg, Vladimir Tolmachev, Joachim Feldwisch

    Argitaratua 2010
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Locally Delivered CD40 Agonist Antibody Accumulates in Secondary Lymphoid Organs and Eradicates Experimental Disseminated Bladder Cancer

    Locally Delivered CD40 Agonist Antibody Accumulates in Secondary Lymphoid Organs and Eradicates Experimental Disseminated Bladder Cancer nork Linda C. Sandin, Anna Orlova, Erika Gustafsson, Peter Ellmark, Vladimir Tolmachev, Thomas H. Tötterman, Sara M. Mangsbo

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR:2377 affibody molecules

    PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR:2377 affibody molecules nork Javad Garousi, Karl Andersson, Bogdan Mitran, MARIE-LOUISE PICHL, Stefan Ståhl, Anna Orlova, John Löfblom, Vladimir Tolmachev

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Imaging of Insulinlike Growth Factor Type 1 Receptor in Prostate Cancer Xenografts Using the Affibody Molecule<sup>111</sup>In-DOTA-Z<sub>IGF1R:4551</sub>

    Imaging of Insulinlike Growth Factor Type 1 Receptor in Prostate Cancer Xenografts Using the Affibody Molecule<sup>111</sup>In-DOTA-Z<sub>IGF1R:4551</sub> nork Vladimir Tolmachev, Jennie Malmberg, Camilla Hofström, Lars Abrahmsén, Thomas Bergman, Anna Sjöberg, Mattias Sandström, Torbjörn Gräslund, Anna Orlova

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT

    Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT nork Dan Sandberg, Vladimir Tolmachev, Irina Velikyan, Helena Olofsson, Anders Wennborg, Joachim Feldwisch, Jörgen Carlsson, Henrik Lindman, Jens Sörensen

    Argitaratua 2017
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Labeled Affibody Molecules

    HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Labeled A... nork Camilla Hofström, Mohamed Altai, Hadis Honarvar, Joanna Strand, Jennie Malmberg, Seyed Jalal Hosseinimehr, Anna Orlova, Torbjörn Gräslund, Vladimir Tolmachev

    Argitaratua 2013
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Pharmacokinetics and red cell utilization of iron(III) hydroxide–sucrose complex in anaemic patients: a study using positron emission tomography

    Pharmacokinetics and red cell utilization of iron(III) hydroxide–sucrose complex in anaemic patients: a study using positron emission tomography nork Soheir Beshara, Hans Lundqvist, Johanna Sundin, Mark Lubberink, Vladimir Tolmachev, Sven Valind, Gunnar Antoni, Bengt Långström, Bo G. Danielson

    Argitaratua 1999
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: